Related Experiment Video
Updated: Jun 3, 2026

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo
Published on: August 11, 2018
The prevalence of antibiotic skin test reactivity in a pediatric population
Sonia Kamboj1, Ejaz Yousef, Stephen McGeady
1Department of Allergy and Immunology, Alfred I. duPont Hospital for Children, Wilmington, Delaware 19803, USA.
Insights
Most children with reported antibiotic allergies do not have true immunologic reactions. Provocative drug challenges in pediatric patients show that over 90% can safely receive antibiotics, avoiding unnecessary avoidance.
Area of Science:
- Pediatric Allergy and Immunology
- Pharmacovigilance
- Clinical Pharmacology
Background:
- Adverse drug reactions (ADRs) are common, but true allergic reactions are rare.
- Most studies on penicillin (PCN) allergy are in adults, suggesting many can safely receive PCN.
- Pediatric antibiotic allergy data is limited, leading to potential overuse of alternative antibiotics.
Purpose of the Study:
- To evaluate outcomes of antibiotic provocative drug challenges in children with a history of ADR.
- To correlate challenge outcomes with predictive factors for true antibiotic allergy.
- To reduce unnecessary antibiotic avoidance in pediatric patients.
Main Methods:
- Retrospective chart review of 96 pediatric patients with antibiotic ADR history.
- Inclusion of skin testing (ST) and/or graded challenges to penicillin, cephalosporins, azithromycin (AZT), or clindamycin.
- Analysis of outcomes based on positive ST or failed challenge events.
Main Results:
- 90.6% of pediatric patients (87/96) tolerated provocative antibiotic challenges.
- Only 9.4% (9/96) had positive ST or failed challenges, indicating true allergy.
- Penicillin allergy was confirmed in 8 of the 9 patients with positive results.
Conclusions:
- True antibiotic allergy in children with a history of ADR is uncommon (<10%).
- Provocative drug challenges are valuable in identifying children who can safely receive antibiotics.
- Unnecessary avoidance of first-line antibiotics can be prevented through appropriate allergy testing.
Abstract:
Although adverse drug reactions (ADRs) are not uncommon, true allergic (i.e., immunologic) reactions are infrequent. Estimates are that only 10% of reported "penicillin (PCN)-allergic" patients have true allergic drug reactions. Most studies of PCN-related ADR have been conducted in adult populations and suggest that the majority of adult patients presenting with PCN allergy history can safely receive the drug. The goal of this study was to examine the outcome of provocative drug challenges to antibiotics in a pediatric population and correlate outcomes with predictive factors. Through chart review, we identified 96 pediatric patients with history of an ADR to antibiotics who underwent skin testing (ST) and/or graded challenges to PCN (n = 52), cephalosporins (n = 7), azithromycin (AZT; n = 24), or clindamycin (n = 4). Of these children with an ADR, 87 (90.6%) tolerated provocative drug challenges and 9 (9.4%) were instructed to continue drug avoidance because of positive ST or failed challenge. Eight of the nine patients continued drug avoidance due to positive PCN ST (n = 4) or ADR during drug PCN challenge (n = 4). All AZT and cephalosporin challenges had negative outcomes, and only one patient did not proceed with the clindamycin challenge after a positive ST. True "antibiotic allergy" denoted by positive ST or failed challenge in patients with a history of ADR occurred in <10% of children included in this study, suggesting that without such testing nearly 90% might be treated with alternative antibiotics unnecessarily.
Related Concept Videos
Allergic Reactions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Allergic Reactions: Anaphylaxis
Drug Toxicity: Allergic Reactions
Pharmacokinetics in Pediatric Patients: Drug Metabolism

